APP and Alzheimer disease: If they were no longer present at the time of the withdrawal of the ISR-suppressing drug, the ISR would not be re-elicited, the AβPP-independent iAβ production pathway would not be unconventionally re-activated, and the outcomes would be the same as described above in the analogous situations for conventional AD.